Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Stamenkovic

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Cancer Research|March 4, 2010
CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastomaYin Xu, Ivan Stamenkovic, Qin Yu
Swiss Medical Weekly|December 4, 2018
Synovial sarcoma: when epigenetic changes dictate tumour developmentNicolo Riggi, Luisa Cironi, Ivan Stamenkovic
Annual Review of Pathology|October 26, 2017
Cancer Metastasis: A Reappraisal of Its Underlying Mechanisms and Their Relevance to TreatmentNicolo Riggi, Michel Aguet, Ivan Stamenkovic
Histochemistry and Cell Biology|October 28, 2008
Tumor-host interactions: the role of inflammationMarie-Aude Le Bitoux, Ivan Stamenkovic
Expert Review of Anticancer Therapy|August 13, 2009
Ewing's sarcoma origin: from duel to dualityNicolo Riggi, Mario-Luca Suva, Ivan Stamenkovic
The New England Journal of Medicine|January 26, 2021
Ewing's SarcomaNicolò Riggi, Mario L Suvà, Ivan Stamenkovic
Expert Review of Anticancer Therapy|February 24, 2011
The cancer stem cell paradigm in Ewing's sarcoma: what can we learn about these rare cells from a rare tumor?Nicolò Riggi, Mario-Luca Suvà, Ivan Stamenkovic
The New England Journal of Medicine|April 14, 2021
Ewing's Sarcoma. ReplyNicolò Riggi, Mario L Suvà, Ivan Stamenkovic
FEBS Letters|June 14, 2002
Interaction with substrate sensitises caspase-3 to inactivation by hydrogen peroxideMark B Hampton, Ivan Stamenkovic, Christine C Winterbourn
Oncogene|August 1, 2002
Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicityEmilio Fiore, Carlo Fusco, Pedro Romero, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Cancer Research|March 4, 2010
CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastomaYin Xu, Ivan Stamenkovic, Qin Yu
Swiss Medical Weekly|December 4, 2018
Synovial sarcoma: when epigenetic changes dictate tumour developmentNicolo Riggi, Luisa Cironi, Ivan Stamenkovic
Annual Review of Pathology|October 26, 2017
Cancer Metastasis: A Reappraisal of Its Underlying Mechanisms and Their Relevance to TreatmentNicolo Riggi, Michel Aguet, Ivan Stamenkovic
Histochemistry and Cell Biology|October 28, 2008
Tumor-host interactions: the role of inflammationMarie-Aude Le Bitoux, Ivan Stamenkovic
Expert Review of Anticancer Therapy|August 13, 2009
Ewing's sarcoma origin: from duel to dualityNicolo Riggi, Mario-Luca Suva, Ivan Stamenkovic
The New England Journal of Medicine|January 26, 2021
Ewing's SarcomaNicolò Riggi, Mario L Suvà, Ivan Stamenkovic
Expert Review of Anticancer Therapy|February 24, 2011
The cancer stem cell paradigm in Ewing's sarcoma: what can we learn about these rare cells from a rare tumor?Nicolò Riggi, Mario-Luca Suvà, Ivan Stamenkovic
The New England Journal of Medicine|April 14, 2021
Ewing's Sarcoma. ReplyNicolò Riggi, Mario L Suvà, Ivan Stamenkovic
FEBS Letters|June 14, 2002
Interaction with substrate sensitises caspase-3 to inactivation by hydrogen peroxideMark B Hampton, Ivan Stamenkovic, Christine C Winterbourn
Oncogene|August 1, 2002
Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicityEmilio Fiore, Carlo Fusco, Pedro Romero, et al.
Pageof 7